Answers are grounded in this paper and cite their sources.
In comparative effectiveness research (CER), investigators often resort to methods of indirect and mixed treatment comparisons, due to the unavailability of head-to-head comparative data from randomized clinical trials for competing treatment options. However, implicit in the available indirect comparison techniques is an assumption of exchangeability, which in practice cannot be conclusively verified. This paper discusses the implications of violations of this assumption, and describes approaches to evaluate its validity and steps that may be taken to minimize the impact on conclusions drawn from such studies.
No takes yet. Share an insight, caveat, or question.
Demissie Alemayehu (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: